101 related articles for article (PubMed ID: 33914050)
61. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.
Fontham ETH; Wolf AMD; Church TR; Etzioni R; Flowers CR; Herzig A; Guerra CE; Oeffinger KC; Shih YT; Walter LC; Kim JJ; Andrews KS; DeSantis CE; Fedewa SA; Manassaram-Baptiste D; Saslow D; Wender RC; Smith RA
CA Cancer J Clin; 2020 Sep; 70(5):321-346. PubMed ID: 32729638
[TBL] [Abstract][Full Text] [Related]
62. ACOG Committee Opinion No. 754: The Utility of and Indications for Routine Pelvic Examination.
Obstet Gynecol; 2018 Oct; 132(4):e174-e180. PubMed ID: 30247363
[TBL] [Abstract][Full Text] [Related]
63. Reducing overuse of cervical cancer screening: A systematic review.
Alber JM; Brewer NT; Melvin C; Yackle A; Smith JS; Ko LK; Crawford A; Glanz K
Prev Med; 2018 Nov; 116():51-59. PubMed ID: 30149037
[TBL] [Abstract][Full Text] [Related]
64. Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force.
Kim JJ; Burger EA; Regan C; Sy S
JAMA; 2018 Aug; 320(7):706-714. PubMed ID: 30140882
[TBL] [Abstract][Full Text] [Related]
65. Periodic Screening Pelvic Examination: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Guirguis-Blake JM; Henderson JT; Perdue LA
JAMA; 2017 Mar; 317(9):954-966. PubMed ID: 28267861
[TBL] [Abstract][Full Text] [Related]
66. Single Health System Adherence to 2012 Cervical Cancer Screening Guidelines at Extremes of Age and Posthysterectomy.
Teoh D; Isaksson Vogel R; Hultman G; Monu M; Downs L; Geller MA; Le C; Melton-Meaux G; Kulasingam S
Obstet Gynecol; 2017 Mar; 129(3):448-456. PubMed ID: 28178049
[TBL] [Abstract][Full Text] [Related]
67. Cervical Cancer Screening Guideline Adherence Before and After Guideline Changes in Pennsylvania Medicaid.
Parekh N; Donohue JM; Men A; Corbelli J; Jarlenski M
Obstet Gynecol; 2017 Jan; 129(1):66-75. PubMed ID: 27926644
[TBL] [Abstract][Full Text] [Related]
68. Harms of cervical cancer screening in the United States and the Netherlands.
Habbema D; Weinmann S; Arbyn M; Kamineni A; Williams AE; M C M de Kok I; van Kemenade F; Field TS; van Rosmalen J; Brown ML
Int J Cancer; 2017 Mar; 140(5):1215-1222. PubMed ID: 27864938
[TBL] [Abstract][Full Text] [Related]
69. Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.
Silver MI; Rositch AF; Burke AE; Chang K; Viscidi R; Gravitt PE
Obstet Gynecol; 2015 Feb; 125(2):317-329. PubMed ID: 25568994
[TBL] [Abstract][Full Text] [Related]
70. Adherence to the 2012 national cervical cancer screening guidelines: a pilot study.
Teoh DG; Marriott AE; Isaksson Vogel R; Marriott RT; Lais CW; Downs LS; Kulasingam SL
Am J Obstet Gynecol; 2015 Jan; 212(1):62.e1-9. PubMed ID: 24992692
[TBL] [Abstract][Full Text] [Related]
71. Screening pelvic examination in adult women: a clinical practice guideline from the American College of Physicians.
Qaseem A; Humphrey LL; Harris R; Starkey M; Denberg TD;
Ann Intern Med; 2014 Jul; 161(1):67-72. PubMed ID: 24979451
[TBL] [Abstract][Full Text] [Related]
72. Utilization patterns of cervical cancer screening in Italy.
Barbadoro P; Ricciardi A; Di Tondo E; Vallorani S; Mazzarini G; Prospero E
Eur J Cancer Prev; 2015 Mar; 24(2):135-40. PubMed ID: 24977627
[TBL] [Abstract][Full Text] [Related]
73. Adherence to cervical cancer screening guidelines by gynecologists in the Pacific Northwest.
Verrilli L; Winer RL; Mao C
J Low Genit Tract Dis; 2014 Jul; 18(3):228-34. PubMed ID: 24633168
[TBL] [Abstract][Full Text] [Related]
74. Current practice patterns in cervical cancer screening in Indiana.
King NR; Kasper KM; Daggy JK; Tucker Edmonds B
Am J Obstet Gynecol; 2014 Mar; 210(3):265.e1-8. PubMed ID: 24412744
[TBL] [Abstract][Full Text] [Related]
75. Overuse of papanicolaou testing among older women and among women without a cervix.
Kepka D; Breen N; King JB; Benard VB; Saraiya M
JAMA Intern Med; 2014 Feb; 174(2):293-6. PubMed ID: 24276745
[TBL] [Abstract][Full Text] [Related]
76. Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers.
Hawkins NA; Benard VB; Greek A; Roland KB; Manninen D; Saraiya M
Prev Med; 2013 Nov; 57(5):641-5. PubMed ID: 24012831
[TBL] [Abstract][Full Text] [Related]
77. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
Perkins RB; Anderson BL; Gorin SS; Schulkin JA
Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
[TBL] [Abstract][Full Text] [Related]
78. Cervical cancer screening overuse and underuse: patient and physician factors.
Almeida CM; Rodriguez MA; Skootsky S; Pregler J; Steers N; Wenger NS
Am J Manag Care; 2013 Jun; 19(6):482-9. PubMed ID: 23844709
[TBL] [Abstract][Full Text] [Related]
79. Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers.
Roland KB; Benard VB; Greek A; Hawkins NA; Manninen D; Saraiya M
Prev Med; 2013 Nov; 57(5):419-25. PubMed ID: 23628517
[TBL] [Abstract][Full Text] [Related]
80. Trends in the overuse of ambulatory health care services in the United States.
Kale MS; Bishop TF; Federman AD; Keyhani S
JAMA Intern Med; 2013 Jan; 173(2):142-8. PubMed ID: 23266529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
